Pathway is an AI-driven medical knowledge platform that distills practice guidance from millions of evidence-based sources into concise summaries to help clinicians stay current and deliver high-quality care. The platform has a fast-growing community of over 350,000 registered healthcare professionals. From its inception in 2020, Pathway has combined physician-vetted data with physician-grade AI to power clinical decision support and search. The company is making its clinical decision support tool open access and has launched Pathway AI in limited beta, its most advanced assistant and search tool. Pathway’s clinical AI assistant scored higher than 97% of human test takers on the USMLE and surpassed the accuracy of MedPaLM 2 on that benchmark. The company plans to use new funding to accelerate technology rollout and expand its reach to clinicians globally. Pathway operates an AI-powered medical knowledge platform that uses natural language processing and machine learning to provide evidence-based answers to clinical questions. Its mobile app is available to healthcare professionals on the Apple App Store and will soon be on Google Play; the company has also released an enterprise version of its clinical decision support technology. Pathway delivers interactive “pathways” that guide clinicians step-by-step through diagnostic approaches and treatments, aggregating more than 1,000 guidelines and over 45,000 graded recommendations across 33 medical specialties. The product is used by clinicians in more than 180 countries and reports a net promoter score of 69. Pathway says it typically reduces decision time from minutes to seconds and aims to help hospitals disseminate their own guidelines more efficiently. The recent $1.3M raise will be used to scale operations and expand software functionality to support additional use cases.

Total raised

$6M

Funding rounds

2

Latest round

Seed

Latest activity

Nov 2023